GlaxoSmithKline (GSK) Fails to deliver data

Key failure to deliver metrics for GlaxoSmithKline:

• Last SEC data release: 2024-11-29
• Last 15 days FTD volume: NZ$6.22 M
• Last 3 months FTD volume: NZ$57.35 M
• Last year FTD volume: NZ$57.35 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for GlaxoSmithKline (GSK) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for GlaxoSmithKline (GSK) - since 2022

GlaxoSmithKline (GSK) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
AstraZeneca AZN	NZ$68.08 M	NZ$0.19 B	🇬🇧 UK
Pfizer PFE	NZ$48.65 M	NZ$0.35 B	🇺🇸 USA
Merck MRK	NZ$24.78 M	NZ$98.35 M	🇺🇸 USA
Novartis NVS	NZ$86.4 M	NZ$0.14 B	🇨🇭 Switzerland
Sanofi SNY	NZ$11.17 M	NZ$72.51 M	🇫🇷 France
Teva Pharmaceutical Industries TEVA	NZ$14.55 M	NZ$40.99 M	🇮🇱 Israel
Dynavax Technologies DVAX	NZ$8.42 M	NZ$32.41 M	🇺🇸 USA